| TGA Action ID |
RC-2025-RN-00765-1 |
| Type of Product |
Medical Device |
| Product Name/Description |
Liquid Assayed Specific Protein Control Level 1 and 3. An in vitro diagnostic medical device (IVD)
Liquid Assayed Specific Protein Control Level 1 Catalogue numbers: PS2682, PS10221 Lots: 686LPC, 708LPC
Liquid Assayed Specific Protein Control Level 2 Catalogue numbers: PS2683, PS10222 Lots: 687LPC, 709LPC
Liquid Assayed Specific Protein Control Level 3 Catalogue numbers: PS2684, PS10223 Lot: 710LPC |
| ARTG Number |
199684 |
| Action Type |
Product Correction |
| Action Level |
Hospital |
| Hazard Classification |
Class II |
| Reason for the Action |
The Rheumatoid Factor (RF) concentrations in Liquid Assayed Specific Protein Controls Level 1 Lots 686LPC and 708LPC have decreased.
Randox have updated the IFU and removed the associated targets and ranges as the controls are at the sensitivity limit of some methods.
RF is now recovering below the assigned range, and this can result in delay in testing patient samples as they may not be able to pass RF IQC. |
| Instructions for Customers/Users |
·Randox Laboratories has updated the targets and ranges for RF in 687LPC, 709LPC and 710LPC.
·Randox Laboratories have removed RF targets and ranges in 686LPC and 708LPC.
·The value sheets have been updated in the IFU and are available on www.randox.com for customers to download.
This action has been closed out on 25/05/2026 |
| Action Commencement Date |
8/09/2025 |
| Responsible Entity |
|
| Contact Information |
02 9615 4640 - Randox Australia |